SMTL ID : 8afc.2 (1 other biounit)

CRYSTAL STRUCTURE OF KRAS-G12C IN COMPLEX WITH COMPOUND 12

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.41 Å

Oligo State

monomer

Ligands

1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)

GDP.1: 16 residues within 4Å: Chain A: A.11, C.12, G.13, V.14, G.15, K.16, S.17, A.18, F.28, N.116, K.117, D.119, L.120, S.145, A.146, K.147 21 PLIP interactions: 21 interactions with chain A Hydrogen bonds: A:A.11, A:G.13, A:V.14, A:G.15, A:K.16, A:S.17, A:A.18, A:N.116, A:K.117, A:K.117, A:A.146, A:K.147 Water bridges: A:K.16, A:S.17, A:S.17, A:S.17, A:D.57 Salt bridges: A:K.16, A:D.119 pi-Stacking: A:F.28, A:F.28

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Broker, J. et al., Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS G12C Inhibitor. J.Med.Chem. (2022)

Release Date

2022-11-09

Peptides

GTPase KRas: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

GTPase KRas

Related Entries With Identical Sequence